(Press-News.org) (PHILADELPHIA) - Glioblastoma is the most common aggressive primary brain tumor, and despite advances in standard treatment, the median survival is about 15 months (compared to 4 months without treatment). Researchers at Thomas Jefferson University have been working on a cancer vaccine that would extend that survival by activating the patient's immune system to fight the brain tumor. A study published online November 13th in the journal Cancer Immunology, Immunotherapy drilled down to the cellular and molecular mechanisms behind the vaccine, paving the way for further development and refinement of this new experimental treatment.
"In recent years, researchers and the public have begun to realize the role that the immune system plays in both cancer prevention and treatment," says senior author Craig Hooper, Ph.D., a Professor in the Department of Cancer Biology at Thomas Jefferson University. "The immune system has great potential for helping fight cancer. This study helps give us a roadmap for future brain cancer vaccines."
The study reports on the results of a second phase 1 clinical trial, after the first phase 1 trial in 2001 lead by David Andrews, M.D., Professor of Neurological surgery at Jefferson, saw tumor shrinkage in eight out of 12 patients tested. The vaccine consisted of portions of the patient's own tumor. Specifically, samples of the patients' tumor were removed during surgery, treated overnight with a drug, and packaged inside a diffusion chamber which was then inserted into the abdomen providing immune cells easy access. The drug in this therapy - antisense oligodeoxynucleootides (AS-ODN) - knocks down IGF-R1, a receptor shown to drive tumor growth and metastasis. Research had shown that blocking this receptor with agents like AS-ODN could cause the tumor cell to self-destruct.
In the original trial, the researchers thought that the molecules from the patient's self-destructing tumor were released through pores in the dime-sized chambers and activating the immune system. Once activated in the abdomen, the immune cells would travel to the brain where they would kill the remaining tumor cells that were not removed by surgery. "But no one had really examined the material coming out of the chambers to find out what was activating the immune response," said Dr. Hooper.
First author Larry Harshyne, Ph.D. an Assistant Professor in the Department of Neurological Surgery at Jefferson, had previously done research on antigen presentation. One form of cell-based antigen are exosomes, small membrane-bound particles that bud off of cells and can activate the immune system. Because exosomes are small enough to pass through the chamber's pores, the researchers tested for their presence in the material that seeped out of the sheaths in the lab. They showed that not only were exosomes present, but that they were released from the chambers in a slow and continual stream, providing an ongoing source for immune-cell activation. The researchers also showed that when exosomes were harvested and given to mouse models of brain tumor, the exosomes alone slowed tumor growth.
Finally, the researchers showed that the AS-ODN molecules used to kill cancer cells also activated the immune system. "We think that the AS-ODN treatment changes the quantity or quality of the exosomes released by the tumor cells," says Dr. Harshyne.
The vaccine was also tested on a new group of 12 patients with recurrent glioblastoma. In this round, six of the 12 patients tested had immune responses to therapy. The patients who did not respond, may have been immune-compromised from chemotherapy, says Dr. Hooper. "The best predictor of a positive clinical outcome from the vaccine was an intact immune system," he added.
In the next phase of clinical trials expected to open in January of 2015, the researchers plan to treat patients immediately after their first brain surgery for tumor removal, before chemotherapy is given. "We expect these patients will stand to benefit most from the treatment," says Dr. Hooper. In addition, the researchers are looking for ways to strengthen the immune response to the vaccine to make it even more effective.
INFORMATION:
The work was supported by the Albert Stevens Foundation (David W. Andrews)
The authors report no conflicts of interest.
For more information, contact Edyta Zielinska, 215-955-5291, edyta.zielinska@jefferson.edu.
About Jefferson -- Health is all we do.
Thomas Jefferson University, Thomas Jefferson University Hospitals and Jefferson University Physicians are partners in providing the highest-quality, compassionate clinical care for patients, educating the health professionals of tomorrow, and discovering new treatments and therapies that will define the future of healthcare. Thomas Jefferson University enrolls more than 3,600 future physicians, scientists and healthcare professionals in the Sidney Kimmel Medical College (SKMC); Jefferson Schools of Health Professions, Nursing, Pharmacy, Population Health; and the Graduate School of Biomedical Sciences, and is home of the National Cancer Institute (NCI)-designated Sidney Kimmel Cancer Center. Jefferson University Physicians is a multi-specialty physician practice consisting of over 650 SKMC full-time faculty. Thomas Jefferson University Hospitals is the largest freestanding academic medical center in Philadelphia. Services are provided at five locations -- Thomas Jefferson University Hospital and Jefferson Hospital for Neuroscience in Center City Philadelphia; Methodist Hospital in South Philadelphia; Jefferson at the Navy Yard; and Jefferson at Voorhees in South Jersey.
Hospitalized premature infants are exposed to unsafe levels of a chemical found in numerous medical products used to treat them, raising questions about whether critically ill newborns may be adversely affected by equipment designed to help save their lives.
The chemical, di(2-ethylhexyl)phthalate (DEHP), is used to increase flexibility of many plastic devices. These products, made from polyvinyl chloride (PVC), include most intravenous tubing, catheters, endotracheal tubes, and fluid and blood product bags. DEHP doesn't bind chemically to PVC, and is able to leach into ...
In a new study, Use of Social Network Sites at Work: Does it Impair Performance?, Postdoctoral Fellow Cecilie Schou Andreassen and colleagues at the University of Bergen's (UiB) Department of Psychosocial Science looked at the consequences of the use of social media during working hours.
Every day, more than one billion people worldwide use social media. This habit has also invaded the workplace, as some research reports that four out of five employees use social media for private purpose during working hours.
Surprisingly, although this type of distraction may potentially ...
Scientists used mathematical models to show that analysing genetic data, alongside a range of other risk factors, could substantially improve the ability to flag up women at highest risk of developing breast cancer.
Their study showed that prevention strategies could be improved by testing not only as currently for major cancer predisposition genes such as BRCA1 and BRCA2 - which identify a small percentage of women at very high risk - but also by factoring in data on multiple gene variants that individually have only a small effect on risk, but are more common in the ...
Researchers at the Bellvitge Biomedical Research Institute of Bellvitge, the Catalan Institute of Oncology and the University Hospital of Bellvitge have participated in an international study published in the journal Cancer Cell that describes how exosomes secreted by tumor cells contain protein and microRNA molecules capable of transform neighboring cells into tumoral cells promoting tumor growth.
What are exosomes?
Exosomes are small vesicles which are secreted by all cells and contain proteins and messenger RNAs and microRNAs. At first it was thought that only functioned ...
Researchers at the ARC Centre of Excellence for Coral Reef Studies (Coral CoE) at James Cook University in Australia have found a way to predict illegal fishing activities to help authorities better protect marine reserves.
Marine reserves are the most common strategy used to protect and maintain marine ecosystems around the world.
The International Convention of Biological Diversity aims to have 10 per cent of the world's marine areas protected by 2020.
Many countries are contributing to this target by protecting remote, offshore areas. For example, the United ...
(SACRAMENTO, Calif.) -- This week's issue of the New England Journal of Medicine features an article that highlights an unprecedented analysis of the nation's childhood head injuries. The study, authored by physicians at UC Davis School of Medicine and Washington University School of Medicine, analyzed more than 43,000 children who were evaluated for head trauma at 25 emergency departments around the United States. In the accompanying supplements, detailed information about these children, their presentations and results will be useful to doctors and helpful to policy makers ...
BOSTON, MA - Sleep disorders are independent risk factors for heart attacks and motor vehicle crashes, which are the two leading causes of death for firefighters in the United States. In a national sample of almost 7,000 firefighters, researchers at Brigham and Women's Hospital (BWH) examined the prevalence of common sleep disorders and their association with adverse health and safety outcomes and found that sleep disorders are highly prevalent, and associated with substantially increased risk of motor vehicle crashes and cardio-metabolic diseases among firefighters.
Findings ...
VIDEO:
NC State researchers have developed a new way to transfer thin semiconductor films, which are only one atom thick, onto arbitrary substrates, paving the way for flexible computing or photonic...
Click here for more information.
Researchers from North Carolina State University have developed a new way to transfer thin semiconductor films, which are only one atom thick, onto arbitrary substrates, paving the way for flexible computing or photonic devices. The technique ...
COLUMBUS, Ohio - In six out of 10 cases, ovarian cancer is diagnosed when the disease is advanced and five-year survival is only 27 percent. A new study suggests that a cancer-killing virus combined with a chemotherapy drug might safely and effectively treat advanced or recurrent forms of the disease.
Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James), led the cell and animal study. Reporting in the journal Clinical Cancer Research, the researchers showed that ...
Some people experience cold not only as feeling cold, but actually as a painful sensation. This applies even to fairly mild temperatures - anything below 20°C. A group of researchers from Lund University in Sweden have now identified the mechanism in the body that creates this connection between cold and pain. It turns out that it is the same receptor that reacts to the pungent substances in mustard and garlic.
Professor of Pharmacology Peter Zygmunt and Professor of Clinical Pharmacology Edward Högestätt have long conducted research on pain and the connection ...
